Glaukos Current Deferred Revenue (Quarterly) Insights

Glaukos Corp. (GKOS)

114.68 -0.87 (-0.75%) USD | NYSE | Dec 30, 12:31

View Current Deferred Revenue (Quarterly) for GKOS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Xtant Medical Holdings, Inc.	--
VolitionRX Ltd.	Upgrade
Catheter Precision, Inc.	--